Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  335,415 results for ""Liver Neoplasms""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.

  • Authors : Xiao MY; Key Laboratory of Ethnomedicine (Minzu University of China), Ministry of Education, Beijing 100081, China; School of Pharmacy, Minzu University of China, Beijing 100081, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Bioorganic chemistry [Bioorg Chem] 2024 Sep; Vol. 150, pp. 107539. Date of Electronic Publication: 2024 Jun 08.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Preclinical human and murine models of hepatocellular carcinoma (HCC).

  • Authors : Sundi PRIO; Lusaka Apex Medical University, Off Mumbwa Road, Lusaka 10101, Zambia; Pan African Organization for Health, Education and Research (POHER), United States.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology; Animals

  • Source: Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2024 Aug; Vol. 48 (7), pp. 102418. Date of Electronic Publication: 2024 Jul 14.Publisher: Elsevier Masson Country of Publication: France NLM ID: 101553659 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Liver Transplant as a Treatment of Primary and Secondary Liver Neoplasms.

  • Authors : Gorji L; Department of Surgery, Kettering Health Dayton, Dayton, Ohio.; Brown ZJ

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery ; Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/secondary

  • Source: JAMA surgery [JAMA Surg] 2024 Feb 01; Vol. 159 (2), pp. 211-218.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589553 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus - Atractylodes Herb Pair in Treating Hepatocellular Carcinoma.

  • Authors : Liang Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People's Republic of China.; Xie Y

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 Jun 11; Vol. 18, pp. 2169-2187. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

How to differentiate between combined hepatocellular carcinoma-cholangiocarcinoma and intrahepatic cholangiocarcinoma with rim arterial phase hyperenhancement?

  • Authors : Zhou C; Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.; Shanghai Institute of Medical Imaging, Shanghai, China.

Subjects: Cholangiocarcinoma*/Cholangiocarcinoma*/Cholangiocarcinoma*/diagnostic imaging ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/diagnostic imaging

  • Source: Abdominal radiology (New York) [Abdom Radiol (NY)] 2024 Sep; Vol. 49 (9), pp. 3015-3023. Date of Electronic Publication: 2024 Mar 01.Publisher: Springer Country of Publication: United States NLM ID: 101674571 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.

  • Authors : Spunt SL; Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.; Xue W

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Sarcoma*/Sarcoma*/Sarcoma*/therapy

  • Source: Cancer [Cancer] 2024 Aug 01; Vol. 130 (15), pp. 2683-2693. Date of Electronic Publication: 2024 Apr 03.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

Read More Add to Saved list
×
Academic Journal

Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes.

  • Authors : Hu R; Macau University of Science and Technology, Faculty of Chinese Medicine, Taipa, Macao, 999078, China; Shenzhen Traditional Chinese Medicine Hospital, Department of Liver Disease, Shenzhen, 518033, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/immunology

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Oct 28; Vol. 333, pp. 118400. Date of Electronic Publication: 2024 May 31.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Kaempferol from Alpinia officinarum hance induces G2/M cell cycle arrest in hepatocellular carcinoma cells by regulating the ATM/CHEK2/KNL1 pathway.

  • Authors : Li X; Hepatobiliary and Liver Transplantation Department of Hainan Digestive Disease Center, Institute of Clinical Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, China; Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education & International Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province & Hainan Provincial Key Laboratory of Research and Development on Tropical Herbs, School of Pharmacy, Hainan Medical University, Haikou, Hainan, 571199, China.

Subjects: Kaempferols*/Kaempferols*/Kaempferols*/pharmacology ; Alpinia*/Alpinia*/Alpinia*/chemistry ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Journal of ethnopharmacology [J Ethnopharmacol] 2024 Oct 28; Vol. 333, pp. 118430. Date of Electronic Publication: 2024 Jun 08.Publisher: Elsevier Sequoia Country of Publication: Ireland NLM ID: 7903310 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT/NF-κB signaling pathway.

  • Authors : Gautam AK; Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Rai Bareli Road, Lucknow 226025, Uttar Pradesh, India.; Kumar P

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Apoptosis*/Apoptosis*/Apoptosis*/drug effects

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Oct 25; Vol. 140, pp. 112813. Date of Electronic Publication: 2024 Aug 01.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression.

  • Authors : Ju L; Medical School of Nantong University, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China.; Luo Y

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/genetics

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Oct 25; Vol. 140, pp. 112873. Date of Electronic Publication: 2024 Aug 03.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  335,415 results for ""Liver Neoplasms""